Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix and Feinstein Institutes Publish In Vivo Alzheimer’s Disease Treatment Data
Home
>
News
>
Oligomerix and Feinstein Institutes Publish In Vivo Alzheimer’s Disease Treatment Data
Print
Oligomerix
>
News
>
Oligomerix and Feinstein Institutes Publish In Vivo Alzheimer’s Disease Treatment Data
Oligomerix and Feinstein Institutes Publish In Vivo Alzheimer’s Disease Treatment Data
Post navigation
Previous Post
Oligomerix Awarded $2.18 Million SBIR Grant for Tau Oligomer Inhibitor for Alzheimer’s Disease and Related Disorders
Next Post
Newly Discovered Drug Is Able To Inhibit Neurotoxic Tau Oligomers In Brains, Paving The Way For A Potential Cure for Alzheimer
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
